News

Filter

Current filters:

Trobalt

No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG

27-02-2012

In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…

EuropeGlaxoSmithKlineNeurologicalPharmaceuticalPricingRegulationTrobalt

Valeant posts rocketing sales and earnings for 2nd-qtr 2011

05-08-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) announced second quarter…

FinancialGenericsPharmaceuticalTrobaltValeant Pharmaceuticals

UK’s NICE adds GlaxoSmithKline Trobalt as new NHS epilepsy option

29-07-2011

UK pharma major GlaxoSmithKline’s Trobalt (retigabine) has been recommended for use in the UK’s…

EuropeGlaxoSmithKlineNeurologicalPharmaceuticalRegulationTrobalt

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga

13-06-2011

Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top